Plasma On Chronic Wounds for Epidermal Regeneration
NCT: NCT05855499 · ACTIVE_NOT_RECRUITING
Brief Summary
Every year, 5 million people throughout Germany suffer from extensive, often chronic wounds. Cold plasma is an innovative therapeutic approach in the treatment of these persistent tissue defects. However, previous therapy options with cold plasma are very time-consuming, especially with increasing wound area, and are also strongly dependent on the skill of the practitioner. This study investigates the effectiveness of a system for reproducible application of cold plasma on larger areas and observes the effect of a 4-week additional plasma treatment on wound healing of large chronic wounds. The patient-related benefit of such an additional treatment will also be evaluated. Both study arms will receive guideline-based wound therapy, which is the current gold standard.
Frequently Asked Questions
What is Plasma On Chronic Wounds for Epidermal Regeneration?
Plasma On Chronic Wounds for Epidermal Regeneration is a clinical trial registered under NCT05855499. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT05855499?
The current status of NCT05855499 (Plasma On Chronic Wounds for Epidermal Regeneration) is: ACTIVE_NOT_RECRUITING.
When did Plasma On Chronic Wounds for Epidermal Regeneration start?
Plasma On Chronic Wounds for Epidermal Regeneration started on 2021-10-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.